XIFAXAN Tablet Ref.[11129] Active ingredients: Rifaximin

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

XIFAXAN tablets contain rifaximin, a non-aminoglycoside semi-synthetic, nonsystemic antibiotic derived from rifamycin SV. Rifaximin is a structural analog of rifampin. The chemical name for rifaximin is (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25-pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca-[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-รก]-benzimidazole-1,15(2H)-dione,25-acetate. The empirical formula is C43H51N3O11 and its molecular weight is 785.9.

The chemical structure is represented below:

XIFAXAN tablets for oral administration are film-coated and contain 200 mg or 550 mg of rifaximin.

Inactive ingredients:

Each 200 mg tablet contains colloidal silicon dioxide, disodium edetate, glycerol palmitostearate, hypromellose, microcrystalline cellulose, propylene glycol, red iron oxide, sodium starch glycolate, talc, and titanium dioxide.

Each 550 mg tablet contains colloidal silicon dioxide, glycerol palmitostearate, microcrystalline cellulose, polyethylene glycol/macrogol, polyvinyl alcohol, red iron oxide, sodium starch glycolate, talc, and titanium dioxide.

Dosage Forms and Strengths

XIFAXAN is a pink-colored biconvex tablet and is available in the following strengths:

  • 200 mg – a round tablet debossed with “Sx” on one side and plain on the other.
  • 550 mg – an oval tablet debossed with “rfx” on one side and plain on the other.
How Supplied

The 200 mg tablet is a pink-colored, round, biconvex tablet with “Sx” debossed on one side and plain on the other.

It is available in the following presentation:

  • NDC 65649-301-03, bottles of 30 tablets

The 550 mg tablet is a pink-colored, oval, biconvex tablet with “rfx” debossed on one side and plain on the other.

It is available in the following presentations:

  • NDC 65649-303-02, bottles of 60 tablets
  • NDC 65649-303-03, carton of 60 tablets, Unit Dose

Salix Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807 USA

Drugs

Drug Countries
XIFAXAN Australia, Brazil, Hong Kong, Malta, Netherlands, New Zealand, Poland, Singapore, United States

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.